Cargando…

Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems

The aim of this study was to enhance the dissolution rate of efavirenz using solid dispersion systems (binary and ternary). A comparison between solvent and fusion method was also investigated. Solid dispersions of efavirenz were prepared using polyethylene glycol 8000, polyvinylpyrrolidone K30 alon...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, P. T., Chuah, J. N., Talekar, Meghna, Gorajana, A., Garg, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783747/
https://www.ncbi.nlm.nih.gov/pubmed/24082345
http://dx.doi.org/10.4103/0250-474X.117434
_version_ 1782285709338476544
author Koh, P. T.
Chuah, J. N.
Talekar, Meghna
Gorajana, A.
Garg, S.
author_facet Koh, P. T.
Chuah, J. N.
Talekar, Meghna
Gorajana, A.
Garg, S.
author_sort Koh, P. T.
collection PubMed
description The aim of this study was to enhance the dissolution rate of efavirenz using solid dispersion systems (binary and ternary). A comparison between solvent and fusion method was also investigated. Solid dispersions of efavirenz were prepared using polyethylene glycol 8000, polyvinylpyrrolidone K30 alone and combination of both. Tween 80 was incorporated to obtain a ternary solid dispersion system. Dissolution tests were conducted and evaluated on the basis of cumulative percentage drug release and dissolution efficiency. Physicochemical characterizations of the solid dispersions were carried out using differential scanning calorimetric, powder X-ray diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy. Dissolution was remarkably improved in both systems compared to pure efavirenz (P<0.05). An optimum ratio was identified at a drug:polymer of 1:10. Incorporation of Tween 80 to 1:10 formulations formed using solvent method showed further improvement in the dissolution rate. Physicochemical characterization results suggested that efavirenz existed in the amorphous form in all the solid dispersion systems providing evidence of improvement in dissolution. No statistically significant difference (P>0.05) in dissolution was observed between the two methods. Binary and ternary solid dispersion systems both have showed a significant improvement in the dissolution rate of efavirenz. Formulations with only polyvinylpyrrolidone K30 showed best dissolution profile and 1:10 was identified as an optimum drug-polymer weight ratio.
format Online
Article
Text
id pubmed-3783747
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37837472013-09-30 Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems Koh, P. T. Chuah, J. N. Talekar, Meghna Gorajana, A. Garg, S. Indian J Pharm Sci Research Paper The aim of this study was to enhance the dissolution rate of efavirenz using solid dispersion systems (binary and ternary). A comparison between solvent and fusion method was also investigated. Solid dispersions of efavirenz were prepared using polyethylene glycol 8000, polyvinylpyrrolidone K30 alone and combination of both. Tween 80 was incorporated to obtain a ternary solid dispersion system. Dissolution tests were conducted and evaluated on the basis of cumulative percentage drug release and dissolution efficiency. Physicochemical characterizations of the solid dispersions were carried out using differential scanning calorimetric, powder X-ray diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy. Dissolution was remarkably improved in both systems compared to pure efavirenz (P<0.05). An optimum ratio was identified at a drug:polymer of 1:10. Incorporation of Tween 80 to 1:10 formulations formed using solvent method showed further improvement in the dissolution rate. Physicochemical characterization results suggested that efavirenz existed in the amorphous form in all the solid dispersion systems providing evidence of improvement in dissolution. No statistically significant difference (P>0.05) in dissolution was observed between the two methods. Binary and ternary solid dispersion systems both have showed a significant improvement in the dissolution rate of efavirenz. Formulations with only polyvinylpyrrolidone K30 showed best dissolution profile and 1:10 was identified as an optimum drug-polymer weight ratio. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3783747/ /pubmed/24082345 http://dx.doi.org/10.4103/0250-474X.117434 Text en Copyright: © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Koh, P. T.
Chuah, J. N.
Talekar, Meghna
Gorajana, A.
Garg, S.
Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
title Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
title_full Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
title_fullStr Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
title_full_unstemmed Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
title_short Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
title_sort formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783747/
https://www.ncbi.nlm.nih.gov/pubmed/24082345
http://dx.doi.org/10.4103/0250-474X.117434
work_keys_str_mv AT kohpt formulationdevelopmentanddissolutionrateenhancementofefavirenzbysoliddispersionsystems
AT chuahjn formulationdevelopmentanddissolutionrateenhancementofefavirenzbysoliddispersionsystems
AT talekarmeghna formulationdevelopmentanddissolutionrateenhancementofefavirenzbysoliddispersionsystems
AT gorajanaa formulationdevelopmentanddissolutionrateenhancementofefavirenzbysoliddispersionsystems
AT gargs formulationdevelopmentanddissolutionrateenhancementofefavirenzbysoliddispersionsystems